|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/282 | |
| A61K 31/337 | |||
| A61K 31/4745 | |||
| A61K 31/513 | |||
| A61K 31/519 | |||
| A61K 31/704 | |||
| A61K 31/7068 | |||
| A61K 33/24 | |||
| A61K 45/06 | |||
| A61K 31/4412 | |||
| A61K 31/4965 | |||
| A61K 31/506 |
| (11) | Patento numeris | 2435041 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10723967.5 |
| Europos patento paraiškos padavimo data | 2010-05-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-04-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-12-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2010/057027 |
| Data | 2010-05-21 |
| (87) | Numeris | WO 2010/136394 |
| Data | 2010-12-02 |
| (30) | Numeris | Data | Šalis |
| 09161111 | 2009-05-26 | EP |
| (72) |
VALSASINA, Barbara, IT
BERIA, Italo, IT
CIAVOLELLA, Antonella, IT
BALLINARI, Dario, IT
PESENTI, Enrico, IT
MOLL, Juergen, IT
|
| (73) |
Nerviano Medical Sciences S.r.l.,
11 Viale Pasteur, 10 P.O. Box 11, 20014 Nerviano (MI),
IT
|
| (54) | Therapeutic combination comprising a PLK1 inhibitor and an antineoplastic agent |
| Therapeutic combination comprising a PLK1 inhibitor and an antineoplastic agent |